Kara O, Acar S, Elibol T. The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation. Med Sci Discov [Internet]. 2022 Jun. 8 [cited 2024 Apr. 25];9(6):324-33. Available from: https://medscidiscovery.com/index.php/msd/article/view/743